Horacio Villalobos | Corbis News | Getty Images
Let’s take a look at some of the companies that are garnering attention in extended trading.
Adobe — Shares plunged more than 10% after the software company issued soft guidance. Adobe gave fourth-quarter revenue guidance in the range of $5.5 billion to $5.55 billion. Analysts surveyed by LSEG had expected revenue of $5.61 billion. Adjusted earnings per share guidance was $4.63 to $4.68, with analysts expecting a profit of $4.67. Meanwhile, third-quarter adjusted profits and revenue beat expectations.
Oracle — Shares of the cloud software company rose nearly 6% after it raised its revenue outlook. The company said during its analyst day on Thursday that it now expects revenue of at least $66 billion in 2026, up from a previous outlook of $65 billion and analysts’ expectations of $64.8 billion, according to FactSet.
Neurosecretory Bioscience — Neuroscience-focused biopharmaceutical companies lost more than 2%. Neurocrine Biosciences reported that its investigational schizophrenia drug rubadaxistat failed to meet its primary endpoint in a Phase 2 trial.
RH — The home furnishings company’s shares rose nearly 19% after second-quarter sales and profit beat expectations. RH reported adjusted earnings of $1.69 per share on sales of $830 million. Analysts surveyed by LSEG were expecting earnings of $1.56 per share on sales of $825 million.
Aptive PLC — Shares of the auto parts company rose 1.7% after CEO Kevin Clark bought about 30,000 shares earlier this week, according to a filing with the Securities and Exchange Commission.
—CNBC’s Nick Wells contributed reporting.
